Post by
hevin on Jan 04, 2022 10:56am
Results soon. Random thoughts
Did we actually lose existing market share, or not gain any in the overall Canadian cannabis growth, or both? For the first time, not going to even estimate gross rev. Praying at this point. One thing for sure, we need to make a less expensive infused beverage; I've made the switch to canna bevs which are far better for me than alcohol, so price is a key... unfortunately I've been buying our competition's drinks, as they're much cheaper. That should not be happening with tilray's might and scale of cost efficiency. Glta longs, may shorty rot in a hole of his own digging.
Comment by
CommonCentsforDollars on Jan 04, 2022 3:21pm
I hear all of what you are saying, biggly. My hopes is to see some significant growth in the Euro/Global market. ACB announced today they made a 10 million dollar cannabis shipment to Israel. Hopefully we have been making some big shipments in the Global market too. I heard Malta ran out of cannabis. Going to be an edge of the seat Qtr report without a doubt.
Comment by
Savage97 on Jan 04, 2022 5:24pm
The analysts following Tilray expect it to perhaps double its 2021 revenues in fiscal 2022. That means that it is possible for Tilray to reach $4 billion in 2024 if its trajectory continues as it has. In other words, it doubles in 2022 to reach $1 billion in revenue. That $1 doubles again in 2023, reaching $2 billion, and then again in 2024 to hit the stated $4 billion goal.